News

December 14, 2014

To rapidly expand the use and power of genomic sequencing for diagnosing and treating rare diseases, Claritas Genomics and NextCODE Health today announced a strategic partnership bringing together global leadership in pediatric medicine and sequence analysis. Claritas Genomics, affiliated with Boston Children’s Hospital, is a CLIA-certified clinical laboratory serving the DNA-based diagnostic testing needs of children’s hospitals that admit hundreds of thousands of patients with genetic disorders every year. NextCODE’s solutions have been developed and proven on the world’s largest...

July 31, 2014

Claritas Genomics, a clinical laboratory serving the DNA-based diagnostic testing needs of children’s hospitals, announced today that it is launching a novel series of clinical assays that combine the flexibility and comprehensiveness of whole exome sequencing with the rigor of deep and focused analysis of variants associated with specific clinical presentations.

The first of these tests, the Claritas Pediatric Neurology Exome is a comprehensive clinical whole exome assay that is tailored to address diagnosis of...

July 24, 2014

Dr. Yiping Shen, a Clinical Genetics Medical Director at Claritas Genomics presented a webinar sponsored by Agilent Technologies on Claritas’s ClariView Array, a microarray designed for patients with autism, developmental delay, or intellectual disability.

More information about the webinar can be found by visiting Agilent’s website.

Visit the ClariView Array webpage to learn more about the microarray....

June 24, 2014

Elizabeth Boudreau, Claritas’s Senior Manager of Information Technology, was invited by Amazon Web Services to speak at the June conference in Washington, DC. The conference, “AWS Government, Education, and Nonprofits Symposium,” invited leaders in public sectors to learn more about how the AWS cloud can support their work. Ms. Boudreau’s presentation, entitled “Enhancing Genetic Computation with AWS” narrated Claritas’s history of using AWS, discussed the challenges and advantages of AWS, and outlined the business impact in using cloud-based computation. More information on the conference...

May 01, 2014

On May 1, 2014 at the Executive War College in New Orleans, Patrice spoke about Claritas Genomics’ evolution into a national genetic testing company. The title of her presentation was “Claritas Genomics: Transforming a Hospital-Based Molecular Lab into a Next-Generation Pediatric Diagnostic Company.”...

April 29, 2014

At the 2014 Executive War College meeting in New Orleans, Patrice spoke with Adam Slone, CEO of Slone Partners about her path to becoming CEO of Claritas Genomics, how to foster a strong company culture, and what traits she looks for in a leadership team.

Video: Career Path

Video: Company Culture

Video: Leadership Traits...

December 05, 2013

KANSAS CITY, Mo. and CAMBRIDGE, Mass., Dec 05, 2013 (GLOBE NEWSWIRE via COMTEX) — Cerner Corp. CERN -0.14% and Claritas Genomics announce that the companies will work together to advance personalized medicine by building tools and connectivity that will better integrate next generation sequence (NGS)-based diagnostic testing into health care practice. The parties will collaborate to develop a rapid, scalable laboratory solution for molecular diagnostics that is tailored to NGS workflows, which are more complex and generate much more data than traditional molecular diagnostic tests....

November 12, 2013

Pediatric hospitals to share data and genomic testing infrastructure for the benefit of patients

Cambridge, MA— Cincinnati Children’s Medical Center has partnered with Claritas Genomics, a company formed by Boston Children’s Hospital and Life Technologies Corporation (NASDAQ: LIFE), to provide genomics-based diagnostics for pediatric patients. Cincinnati Children’s will work with Claritas and Boston Children’s to build a collaborative network to enable pediatric hospitals to share data, expertise, best practices and infrastructure in medical...

October 21, 2013

BOSTON, MA /PRNewswire/ — Claritas Genomics, together with partners Life Technologies (NASDAQ: LIFE) and Lockheed Martin (NYSE: LMT), announced today that the Veterans Administration (VA) has awarded Claritas a contract to sequence the exomes of 18,000 military veterans over the next 12 months, one of the largest sequencing projects ever in the US. The project is the first step in the VA’s Million Veteran Program (MVP), which will ultimately sequence 1 million veterans and establish one of the largest databases of genetic, lifestyle, and health information. This vast...

January 08, 2013

Spinoff venture will develop genomic sequencing solutions utilizing Ion Torrent technology for clinical applications

SAN FRANCISCO, CA /PRNewswire-USNewswire/ — Boston Children’s Hospital has partnered with Life Technologies Corporation(NASDAQ: LIFE) to launch Claritas Genomics, a new company formed to develop next-generation,...

About Claritas

Claritas Genomics serves children affected with complex genetic disorders by providing timely and accurate results, resolving families’ long search for answers. By combining clinical expertise of the world’s best pediatric specialists with innovative platform solutions, Claritas is working to improve patient care and enable new discoveries. We are committed to the highest quality and accessibility of information and our interpretive services and unique approach to reporting set the standard for reliably and clearly communicating genetic information.

Now is the time to integrate genomics into clinical practice to inform, guide and improve medical treatment for kids around the world.